ReposiTrak(TRAK) - 2019 Q2 - Quarterly Report

Revenue Performance - Revenue for the three months ended December 31, 2018, was $5,724,706, a 3% decrease from $5,565,237 in the same period of 2017[77] - Revenue for the six months ended December 31, 2018, was $11,507,231, reflecting a 10% increase from $10,436,871 in the same period of 2017[89] - Management anticipates revenue growth in subsequent periods driven by new customer acquisition and cross-selling existing services[78] Expenses - Cost of services and product support decreased by 11% to $1,270,659 for the three months ended December 31, 2018, compared to $1,426,351 in 2017[79] - Cost of services and product support for the six months ended December 31, 2018, increased by 5% to $2,999,185 from $2,844,364 in 2017[90] - Sales and marketing expenses dropped by 30% to $1,139,855 for the three months ended December 31, 2018, down from $1,621,149 in 2017[81] - Sales and marketing expenses for the six months ended December 31, 2018, decreased by 5% to $3,047,879 compared to $3,207,089 in 2017[91] - General and administrative expenses increased by 16% to $1,326,735 for the three months ended December 31, 2018, compared to $1,140,085 in 2017[83] - General and administrative expenses rose by 9% to $2,470,046 for the six months ended December 31, 2018, up from $2,275,855 in 2017[92] Net Other Income - Net other income for the three months ended December 31, 2018, was $49,150, a significant increase from a net expense of $7,696 in 2017, marking a 739% change[86] - Net other income for the six months ended December 31, 2018 was $73,801, a significant increase of 347% compared to a net other expense of $29,887 for the same period in 2017[95] Cash Flow and Liquidity - Cash and cash equivalents increased by 12% to $16,682,282 as of December 31, 2018, up from $14,892,439 as of June 30, 2018, primarily due to higher cash flows from operations[99] - Net cash provided by operating activities rose by 34% to $1,830,582 for the six months ended December 31, 2018, compared to $1,368,613 in the same period of 2017[100] - Cash used in investing activities decreased by 99% to $3,547 for the six months ended December 31, 2018, down from $288,884 in the prior year, due to reduced fixed asset purchases[101] - Cash used in financing activities decreased by 88% to $37,192 for the six months ended December 31, 2018, compared to $315,227 in the same period of 2017, mainly due to lower dividend payments[102] - The company believes its existing cash and short-term investments are sufficient to fund operations for at least the next twelve months[98] Balance Sheet - Current assets increased by 5% to $25,027,283 as of December 31, 2018, compared to $23,733,461 as of June 30, 2018, driven by a rise in cash[104] - Current liabilities rose by 19% to $9,542,741 as of December 31, 2018, up from $7,989,892 as of June 30, 2018, primarily due to increased amounts drawn on the line of credit[105] - Working capital decreased by $259,027 to $15,484,542 as of December 31, 2018, compared to $15,743,569 at June 30, 2018[103] - Total debt as of December 31, 2018, is $4,954,977, with fixed rate debt at $294,977 (6%) and variable rate debt at $4,660,000 (94%) [121] Investment Portfolio - The fair value of cash in the investment portfolio is $16,682,282, with a weighted average interest rate of 2.21% [121] Internal Controls - The Chief Executive Officer and Chief Financial Officer believe that the company's disclosure controls and procedures are effective as of December 31, 2018 [124] - There have been no changes in the company's internal control over financial reporting that materially affected or are likely to materially affect the company's internal control during the reporting period [124]